Janus Henderson Group PLC Neogenomics Inc Transaction History
Janus Henderson Group PLC
- $187 Billion
- Q3 2024
A detailed history of Janus Henderson Group PLC transactions in Neogenomics Inc stock. As of the latest transaction made, Janus Henderson Group PLC holds 6,603,180 shares of NEO stock, worth $109 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
6,603,180
Previous 6,619,336
0.24%
Holding current value
$109 Million
Previous $91.8 Million
6.08%
% of portfolio
0.05%
Previous 0.05%
Shares
30 transactions
Others Institutions Holding NEO
# of Institutions
294Shares Held
124MCall Options Held
698KPut Options Held
120K-
Black Rock Inc. New York, NY19.7MShares$325 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$232 Million0.0% of portfolio
-
Brown Advisory Inc6.89MShares$114 Million0.13% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.54MShares$108 Million0.06% of portfolio
-
State Street Corp Boston, MA4.96MShares$82 Million0.0% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $2.08B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...